Dr. Ted Pincus (ClinDat) 聯繫信件
目標：探討風濕科學術合作 優先級：中（Phase 3） 聯繫方式：tedpincus@gmail.com
信件內容
Subject: Academic Collaboration: AI-Powered Drug Repurposing for Rheumatic Diseases - TwTxGNN x ClinDat
Dear Dr. Pincus,
I am writing to explore a potential academic collaboration between TwTxGNN and ClinDat, your rheumatology monitoring platform.
About TwTxGNN
TwTxGNN is an open-source drug repurposing platform that leverages Harvard's TxGNN knowledge graph model (published in Nature Medicine, 2023) to predict potential new indications for existing medications.
Our Autoimmune Disease Coverage:
- 17 drugs with autoimmune disease predictions
- 16 predicted indications including rheumatoid arthritis, lupus, and other rheumatic conditions
- L1-L5 evidence classification with ClinicalTrials.gov and PubMed validation
Website: https://twtxgnn.yao.care/ GitHub: https://github.com/yao-care/TwTxGNN
Why This Collaboration
Your pioneering work on RAPID3 (Routine Assessment of Patient Index Data) and patient-reported outcomes in rheumatology provides a unique opportunity for drug repurposing validation:
-
Outcome-Based Validation: ClinDat's disease activity tracking (DAS28, RAPID3) can help validate whether AI-predicted drug candidates actually improve patient outcomes.
-
Treatment-Resistant Patients: When disease activity scores indicate inadequate treatment response, TwTxGNN predictions can suggest alternative therapeutic options.
-
Real-World Evidence: Combining AI predictions with ClinDat's longitudinal patient data could generate valuable real-world evidence.
Proposed Collaboration
- Data Integration
- Display TwTxGNN drug repurposing candidates within ClinDat workflow
- Trigger suggestions when RAPID3/DAS28 scores indicate poor response
- Validation Study
- Track outcomes of patients who receive repurposed drugs
- Generate evidence for AI prediction validation
- Publication Opportunity
- Joint publication on AI-assisted rheumatology decision support
- Contribute to the evidence base for precision rheumatology
Technical Compatibility
| Item | TwTxGNN | ClinDat |
|---|---|---|
| FHIR Version | R4 | DSTU2 (upgradeable) |
| Data Format | JSON/FHIR | Proprietary |
| Integration | API available | SMART App |
Next Steps
Would you be interested in:
- A brief call to discuss the collaboration concept?
- Reviewing our autoimmune disease drug predictions?
- Exploring a pilot integration study?
I greatly admire your contributions to quantitative rheumatology and believe this collaboration could benefit patients with treatment-resistant rheumatic diseases.
Best regards,
TwTxGNN Team https://twtxgnn.yao.care/
附件清單
- 英文版專案簡介：project-intro-en.md
- 自體免疫疾病藥物預測清單
背景資料
Dr. Ted Pincus
- 風濕科醫師，RAPID3 評分系統開發者
- 長期倡導病患自我評估在風濕病學的應用
- ClinDat 平台創建者
RAPID3 評分
- Routine Assessment of Patient Index Data 3
- 包含：功能性、疼痛、整體評估
- 計分範圍：0-30
- 可在 10 秒內完成評估
待辦事項
- 發送聯繫信件
- 整理 TwTxGNN 風濕疾病相關預測資料
- 準備學術合作提案
- 安排視訊會議
- 準備 IRB 相關文件（若需要）
建立日期：2026-03-01